We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AX icon
426
Axos Financial
AX
$5.9B
$2.35M 0.02%
106,394
-3,700
-3% -$75.2K
SRI icon
427
Stoneridge
SRI
$210M
$2.33M 0.02%
112,933
-3,800
-3% -$71.2K
VRTX icon
428
Vertex Pharmaceuticals
VRTX
$119B
$2.32M 0.02%
+8,000
New +$2.17M
SSNC icon
429
SS&C Technologies
SSNC
$18.6B
$2.3M 0.02%
40,800
-2,400
-6% -$131K
KDP icon
430
Keurig Dr Pepper
KDP
$42.1B
$2.24M 0.02%
78,900
-4,300
-5% -$117K
BNY
431
Bank of New York Mellon
BNY
$106B
$2.23M 0.02%
+57,600
New +$2.11M
AAP icon
432
Advance Auto Parts
AAP
$3.36B
$2.22M 0.02%
15,600
-800
-5% -$102K
CNO icon
433
CNO Financial Group
CNO
$5.16B
$2.19M 0.02%
140,882
-3,500
-2% -$48.2K
CMD
434
DELISTED
Cantel Medical Corporation
CMD
$2.16M 0.02%
48,740
+21,200
+77% +$791K
AVB icon
435
AvalonBay Communities
AVB
$27B
$2.15M 0.02%
13,875
CTRE icon
436
CareTrust REIT
CTRE
$9.74B
$2.12M 0.02%
123,599
-3,600
-3% -$62.9K
HTH icon
437
Hilltop Holdings
HTH
$2.28B
$2.11M 0.02%
114,274
-3,900
-3% -$67K
MSI icon
438
Motorola Solutions
MSI
$72.6B
$2.06M 0.02%
14,725
-38,950
-73% -$5.51M
MPT
439
Medical Properties Trust
MPT
$2.75B
$2.06M 0.02%
109,332
-5,800
-5% -$103K
PI icon
440
Impinj
PI
$4.93B
$2.05M 0.02%
74,782
-1,900
-2% -$44.5K
LH icon
441
Labcorp
LH
$24.9B
$2.04M 0.02%
14,317
-815
-5% -$113K
GS icon
442
Goldman Sachs
GS
$303B
$1.9M 0.01%
9,600
+2,200
+30% +$413K
MET icon
443
MetLife
MET
$62B
$1.85M 0.01%
50,700
+12,900
+34% +$449K
CPRT icon
444
Copart
CPRT
$27.2B
$1.75M 0.01%
842,500
-10,800
-1% -$217K
SYK icon
445
Stryker
SYK
$131B
$1.75M 0.01%
9,700
-500
-5% -$92.2K
VREX icon
446
Varex Imaging
VREX
$502M
$1.52M 0.01%
100,629
+13,500
+15% +$272K
CAKE icon
447
Cheesecake Factory
CAKE
$5.21B
$1.5M 0.01%
65,264
-1,400
-2% -$29.5K
RTX icon
448
RTX Corp
RTX
$292B
$1.4M 0.01%
22,773
-14,569
-39% -$909K
AVTA
449
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.29M 0.01%
113,425
-3,900
-3% -$49K
ATRO icon
450
Astronics
ATRO
$3.51B
$1.29M 0.01%
146,714
-4,200
-3% -$32.8K

Similar funds

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.